LULICONAZOLE 1%w/w IP

A novel topical antifungal imidazole with broad-spectrum that treats infections caused by a fungus or yeast. (Hiroyasu Koga, 2012) A very potent molecule against pathogenic fungi isolated from patients with dermatomycoses. (Hiroyasu Koga 1, 2006) Resolves the signs and symptoms as well as eradicates the pathologic fungi, which cause tinea pedis. (Aditya K Gupta, 2016) Has strong fungicidal activity against Trichophyton species. (Michael H Gold, 2015) The most potent antifungal agent among the major topical antimycotics. (Jun Maeda, 2016) More effective drug than bifonazole, terbinafine, and lanoconazole for the treatment of tinea pedis. (Michael Jarratt, 2013) A well-tolerated and effective agent in patients with tinea pedis. (Michael Jarratt T. J.-M., 2014) An effective drug for short-term treatment for dermatophytosis compared to existing drugs. (Hiroyasu Koga, 2012) An alternative solution in topical therapy for dermatomycoses caused by Trichophyton species. (Sebastian Gnat, 2021) Demonstrates significantly higher antifungal activity than terbinafine against dermatomycoses. (Sebastian Gnat, 2021)